Commonwealth Equity Services’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,069
Closed -$2K 2822
2018
Q4
$2K Sell
25,069
-5,555
-18% -$3.65K ﹤0.01% 2675
2018
Q3
$52K Sell
30,624
-11,142
-27% -$19.9K ﹤0.01% 2692
2018
Q2
$73K Sell
41,766
-874
-2% -$1.51K ﹤0.01% 2633
2018
Q1
$78K Buy
42,640
+3,271
+8% +$6.91K ﹤0.01% 2564
2017
Q4
$88K Buy
39,369
+14,035
+55% +$34.9K ﹤0.01% 2524
2017
Q3
$73K Buy
25,334
+298
+1% +$1.02K ﹤0.01% 2444
2017
Q2
$111K Buy
25,036
+1,107
+5% +$4.57K ﹤0.01% 2361
2017
Q1
$112K Buy
23,929
+5,523
+30% +$32K ﹤0.01% 2271
2016
Q4
$112K Buy
+18,406
New +$96.2K ﹤0.01% 2178

Other funds holding SGYP

Commonwealth Equity Services's SGYP Position: Q1 2019 in Review

Commonwealth Equity Services sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 25,069 shares — an estimated $2K sold.

Commonwealth Equity Services first reported a position in SGYP in Q4 2016 and held it in 9 quarters. The position peaked at $112K in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Commonwealth Equity Services reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Commonwealth Equity Services sold 25,069 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
  • Commonwealth Equity Services first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 9 quarters.
  • Commonwealth Equity Services's Synergy Pharmaceuticals, Inc Common Stock position peaked at $112K in Q1 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Commonwealth Equity Services's 13F filing for Q1 2019, filed 13 May 2019.